Search Results - The MMR-162 Study Group
- Showing 1 - 1 results of 1
-
1
Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study by The MMR-162 Study Group
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book